De Rode Hoed, Amsterdam, Netherlands
01 - 03 February 2018
Evading cell death is a hallmark of cancer cells, which contributes to tumour growth and therapeutic resistance. But cancer cells also highjack mechanisms like protective autophagy or senescence to promote tumour growth. Cell death is an important determinant of the immune response to cancer, which may either increase the antitumour effect or promote tumour growth. The conference will cover exciting new insights into this highly-relevant field, so please join us in Amsterdam to be stimulated by the latest research updates! Who should attend? With its translational character, the conference has been designed for basic and translational cancer scientists, as well as oncologists who are interested in the multifaceted role of cell death in cancer. We strongly encourage early-stage basic cancer researchers and medical oncologists to present their work to the international community. There will be plenty of opportunities for interaction with some of the top experts in the field, including Round Table Discussions. We anticipate an inspiring informal atmosphere to share research findings, and to establish or strengthen collaborations.
|
|
Invited Speakers:
|
|
Christian Behrends (Germany), Peter de Keizer (Netherlands), Karin de Visser (Netherlands), Sandra Demaria (USA), Scott Dixon (USA), Simone Fulda (Germany), Ana J. García-Sáez (Germany), Verena Jendrossek (Germany), Jan Paul Medema (Netherlands), Manolis Pasparakis (Germany), Eugenia Piddini (UK), Kevin Ryan (UK), John Silke (Australia), Giorgio Stassi (Italy), Stephen Tait (UK), Guillermo Velasco (Spain), Andreas Villunger (Austria)
|
|